Therapeutic challenges in childhood sickle cell disease. Part 2: A problem-orientated approach

British Journal of Haematology

Volumn 120, Issue 5, 2003, Pages 737-743

  Amrolia, Persis J ^a   Almeida, Antonio ^b   Davies, Sally C ^c   Roberts, Irene A G ^b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Chest crisis; Hydroxyurea; Sickle cell disease; Stroke; Vaso occlusive crisis

Indexed keywords

ALLOANTIBODY; BUSULFAN; HEMOGLOBIN F; HYDROXYUREA;

ACUTE CHEST SYNDROME; ALLOIMMUNIZATION; BLOOD TRANSFUSION; BLOOD VESSEL OCCLUSION; BONE MARROW TOXICITY; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CHILDHOOD; CLINICAL TRIAL; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; INFERTILITY; IRON CHELATION; LEUKEMOGENESIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PAIN; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; STROKE; SURVIVAL;

ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BONE MARROW TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASES; CEREBROVASCULAR ACCIDENT; CHEST PAIN; CHILD; CONSTRICTION, PATHOLOGIC; ERYTHROCYTE TRANSFUSION; HUMANS; HYDROXYUREA; RECURRENCE; SYNDROME; VASCULAR DISEASES;

EID: 0037338359     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04144.x     Document Type: Review

References (47)

1. Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D.L., McKie, K., Figueroa, R., Litaker, M., Thompson, W. & Hess, D. (1992) The use of transcranial ultrasonography to predict stroke in sickle cell disease. New England Journal of Medicine, 326, 605-610.
2. Adams, R.J., McKie, V.C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F.T., Bonds, D.R. & Brambilla, D. (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. New England Journal of Medicine, 339, 5-11.
3. Ballas, S.K. (2001) Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease. Seminars in Hematology, 38, 30-36.
4. Bernaudin, F., Souillet, G., Vannier, J.P., Vilmer, C., Michel, G., Lutz, P., Pouvier, E., Bordigoni, P., Marguerritte, G., Kuentz, M. & Vernant, J.P. (1997) Report of the French experience concerning 26 children transplanted for severe sickle cell disease. Bone Marrow Transplantation. 19, 112-115.
5. Castro, O. (1999) Management of sickle cell disease: recent advances and controversies. British Journal of Haematology, 107, 2-11.
6. Castro, O., Brambilla, D.J., Thorington, B., Reindorf, C.A., Scott, R.B., Gillette, P., Vera, J.C. & Levy, P.S. (1994) The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood, 84, 643-649.
7. Charache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., McMahon, R.P. & Bonds, D.R. (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. New England Journal of Medicine, 332, 1317-1322.
8. Ferster, A., Corazza, F., Vertongen, F., Bujan, W., Devalck, C., Fondu, P., Cochaux, P., Lambermont, M., Khaladji, Z. & Sariban, E. (1995) Transplanted sickle-cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity. British Journal of Haematology, 90, 804-808.
9. Ferster, A., Tahriri, P., Vermylen, C., Sturbois, G., Corazza, F., Fondu, P., Devalck, C., Dresse, M.F., Feremans, W., Hunninck, K., Toppet, M., Philippet, P., Van Geet, C. & Sariban, E. (2001) Five years of experience with hydroxyurea in children and young adults with sickle cell disease, Blood, 97, 3628-3632.
10. Gray, A., Anionwu, E.N., Davies, S.C. & Brozovic, M. (1991) Patterns of mortality in sickle cell disease in the United Kingdom. Journal of Clinical Pathology, 44, 459-463.
11. Halsey, C. & Roberts, I.A.G. (2003) The role of hydroxyurea in sickle cell disease. British Journal of Haematology (in press).
12. Hickman, M., Modell, B., Greengross, P., Chapman, C., Layton, M., Falconer, S. & Davies, S.C. (1999) Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates. British Journal of Haematology. 104, 860-867.
13. Jayabose, S., Tugal, O., Sandoval, C., Patel, P., Puder, D., Lin, T. & Visintainer, P. (1996) Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia. Journal of Pediatrics, 129, 559-565.
14. Kinney, T.R., Helms, R.W., O'Branski, E.E., Ohene-Frempong, K., Wang, W., Daeschner, C., Vichinsky, E., Redding-Lallinger, R., Gee, B., Platt, O.S. & Ware, R.E. (1999) Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood, 94, 1550-1554.
15. Koren, A., Segal-Kupershmit, D., Zalman, L., Levin, C., Abu, H.M., Palmor, H., Luder, A. & Attias, D. (1999) Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia. Pediatric Hematology and Oncology, 16, 221-232.
16. Koshy, M., Burd, L., Wallace, D., Moawad, A. & Baron, J. (1988) Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study. New England Journal of Medicine, 319, 1447-1452.
17. Lee, A., Thomas, P., Cupidore, L., Serjeant, B. & Serjeant, G. (1995) Improved survival in homozygous sickle cell disease: lessons from a cohort study. British Medical Journal, 311, 1600-1602.
18. Maier-Redelsperger, M., Labie, D. & Elion, J. (1999) Long-term hydroxyurea treatment in young sickle cell patients. Current Opinions in Hematology, 6, 115-120.
19. Nietert, P.J., Abboud, M.R., Silverstein, M.D. & Jackson, S.M. (2000) Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood, 95, 3057-3064.
20. Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Pegelow, C.H. & Gill, F.M. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288-294.
21. Pegelow, C.H., Adams, R.J., McKie, V., Abboud, M., Berman, B., Miller, S.T., Olivieri, N., Vichinsky, E., Wang, W. & Brambiila, D. (1995) Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. Journal of Pediatrics, 126, 896-899.
22. Pegelow, C.H., Wang, W., Granger, S., Hsu, L.L., Vichinsky, E., Moser, F.G., Bello, J., Zimmerman, R.A., Adams, R.J. & Brambilla, D. (2001) STOP trial: silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Archives of Neurology, 58, 2017-2221.
23. Pegelow, C.H., Macklin, E.A., Moser, F.G., Wang, W.C., Bello, J.A., Miller, S.T., Vichinsky, E.P., DeBaun, M.R., Guarini, L., Zimmerman, R.A., Younkin, D.P., Gallagher, D.M. & Kinney, T.R. (2002) Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood, 99, 3014-3018.
24. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine, 330, 1639-1644.
25. Powars, D., Wilson, B., Imbus, C., Pegelow, C. & Allen, J. (1978) The natural history of stroke in sickle cell disease. American Journal of Medicine. 65, 461-471.
26. Powars, D., Weidman, J.A., Odom-Maryon, T., Niland, J.C. & Johnson, C. (1988) Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore). 67, 66-76.
27. Powars, D.R., Conti, P.S., Wong, W.Y., Groncy, P., Hyman, C., Smith, E., Ewing, N., Keenan, R.N., Zee, C.S., Harold, Y., Hiti, A.L., Teng, E.L. & Chan, L.S. (1999) Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. Blood, 93, 71-79.
28. Rana, S., Houston, P.E., Surana, N., Shalaby-Rana, E.I. & Castro, O.L. (1997) Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke. Journal of Pediatrics, 131, 757-760.
29. Reisner, E.G., Kostyu, D.D., Phillips, G., Walker, C. & Dawson, D.V. (1987) Alloantibody responses in multiply transfused sickle cell patients. Tissue Antigens, 30, 161-166.
30. Rosse, W.F., Narla, M., Petz, L.D. & Steinberg, M.H. (2000) New views of sickle cell disease pathophysiology and treatment. Hematology 2000 (American Society of Hematology Educational Program), 2-17. American Society of Hematology, Washington DC.
31. Russell, M.O., Goldberg, H.I., Hodson, A., Kim, H.C., Halus, J., Reivich, M. & Schwartz, E. (1984) Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood, 63, 162-169.
32. Scothorn, D.J., Price, C., Schwartz, D., Terrill, C., Buchanan, G.R., Shurney, W., Sarniak, I., Fallon, R., Chu, J.Y., Pegelow, C.H., Wang, W., Casella, J.F., Resar, L.S., Berman, B., Adamkiewicz, T., Hsu, L.L., Ohene-Frempong, K., Smith-Whitley, K., Mahoney, D., Scott, J.P., Woods, G.M., Watanabe, M. & Debaun, M.R. (2002) Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. Journal of Pediatrics. 140, 348-354.
33. Steen, R.G., Helton, K.J., Horwitz, E.M., Benaim, E., Thompsen, S., Bowman, L.C., Krance, R., Wang, W.C. & Cunningham, J.M. (2001) Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts. Annals of Neurology. 49, 222-229.
34. Steinberg, M.H. (1999) Management of sickle cell disease. New England Journal of Medicine. 340, 1021-1030.
35. Vermylen, C., Cornu, G., Ferster, A., Brichard, B., Ninane, J., Ferrant, A., Zenebergh, A., Maes, P., Dhooge, C., Benoit, Y., Beguin, Y., Dresse, M.F. & Sariban, E. (1998) Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplantation, 22, 1-6.
36. Vichinsky, E. (2001) Current issues with blood transfusion in sickle cell disease. Seminars in Hematology, 38, 14-22.
37. Vichinsky, E.P. & Lubin, B.H. (1994) A cautionary note regarding hydroxyurea in sickle cell disease. Blood, 83, 1124-1128.
38. Vichinsky, E.P., Earles, A., Johnson, R.A., Hoag, M.S., Williams, A. & Lubin, B. (1990) Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. New England Journal of Medicine. 322, 1617-1621.
39. Vichinsky, E., Neumayr, L.D., Earles, A.N., Williams, R., Lennette, E.T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C., Manci-Gardner, E., Abboud, M., Moncino, M., Ballas, S. & Ware, R. (2000) Causes and outcome of the acute chest syndrome in sickle cell disease. New England Journal of Medicine, 342, 1855-1865.
40. Walters, M.C., Patience, M., Leisenring, W., Eckman, J.R., Scott, J.P., Mentzer, W.C., Davies, S.C., Ohene-Frempong, K., Bernaudin, F., Matthews, D.C., Storb, R. & Sullivan, K.M. (1996a) Bone marrow transplantation for sickle cell disease. New England Journal of Medicine, 335, 369-376.
41. Walters, M.C., Patience, M., Leisenring, W., Eckman, J.R., Buchanan, G.R., Rogers, Z.R., Olivieri, N.F., Vichinsky, E., Davies, S.C., Mentzer, W.C., Powars, D., Scott, J.P., Bernaudin, F., Ohene-Frempong, K., Darbyshire, P.J., Wayne, A., Roberts, I.A.G., Dindorf, P., Brandalise, S., Sanders, J.E., Matthews, D.C., Appelbaum, F.R., Storb, R. & Sullivan, K.M. (1996b) Barriers to bone marrow transplantation for sickle cell anemia. Biology of Blood and Marrow Transplantation, 2, 100-104.
42. Walters, M.C., Storb, R., Patience, M., Leisenring, W., Taylor, T., Sanders, J.E., Buchanan, G.E., Rogers, Z.R., Dinndorf, P., Davies, S.C., Roberts, I.A., Dickerhoff, R., Yeager, A.M., Hsu, L., Kurtzberg, J., Ohene-Frempong, K., Bunin, N., Bernaudin, F., Wong, W.Y., Scott, J.P., Margolis, D., Vichinsky, E., Wall, D.A., Wayne, A.S., Pegelow, C., Redding-Lallinger, R., Wiley, J., Klemperer, M., Mentzer, W.C., Smith, F.O. & Sullivan, K.M. (2000) Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood, 95, 1918-1924.
43. Wang, W.C., Kovnar, E.H., Tonkin, I.L., Mulhern, R.K., Langston, J.W., Day, S.W., Schell, M.J. & Wilimas, J.A. (1991) High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. Journal of Pediatrics. 118, 377-382.
44. Wang, W.C., Wynn, L.W., Rogers, Z.R., Scott, J.P., Lane, P.A. & Ware, R.E. (2001) A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. Journal of Pediatrics. 139, 790-796.
45. Ware, R.E., Zimmerman, S.A. & Schultz, W.H. (1999) Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with SCD. Blood. 94, 3022-3026.
46. Ware, R.E., Eggleston, B., Redding-Lallinger, R., Wang, W.C., Smith-Whitley, K., Daeschner, C., Gee, B., Styles, L.A., Helms, R.W., Kinney, T.R. & Ohene Frempong, K. (2000) Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood, 99, 10-14.
47. Ware, R.E., Eggleston, B., Redding-Lallinger, R., Wang, W.C., Smith-Whitley, K., Daeschner, C., Gee, B., Styles, L.A., Helms, R.W., Kinney, T.R. & Ohene-Frempong, K. (2002) Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood. 99, 10-14.